As a division of Rokshaw Laboratories, an MHRA-approved Specials’ manufacturer and importer, Curaleaf Pharmacy is able to provide unlicensed medicines and controlled drugs, bespoke to patient requirements in an EU GMP environment to ensure that patients across the UK receive the highest quality products. Rokshaw has already manufactured more than 7,000 formulations for over 2,000 patients, clinics, pharmacies and hospitals for private and NHS prescriptions across the UK.
Rokshaw’s experienced team has extensive regulatory, formulations, production and import capabilities and holds the following licenses:
- MHRA Specials Manufacturing License (MS)
- MHRA Wholesale Distribution Authorisation (WDA)
- Home Office Controlled Drugs License
- MHRA Import License (IMP)
In addition to the existing licenses, Rokshaw is pursuing additional licenses to facilitate greater research into the benefits of CBPMs.
Curaleaf Pharmacy, as owned by Rokshaw Laboratories is part of the EMMAC Life Sciences Group, the leading European medical cannabis company, bringing together cutting-edge scientific research with the latest innovations in cannabis cultivation, extraction and production to deliver the highest quality medical cannabis product for the patient.